Full Press Release Details
Chief Financial Officer
Integrated Corporate Relations, Inc.
Cutera Reports Second Quarter 2010 Results
BRISBANE, Calif., August 2, 2010 -- Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the second quarter ended June 30, 2010.
Second quarter 2010 revenue was $12.2 million, compared to $11.7 million in the same period last year. Net loss for the second quarter of 2010 was $3.8 million, or $0.28 per diluted share.
Kevin Connors, President and CEO of Cutera, stated, "We experienced quarterly revenue growth year-over-year for the first time since the second quarter of 2008. During the second quarter of 2010, our U.S. revenue increased 5% and our international revenue increased 4%, when compared to the second quarter of 2009. Additionally, we experienced revenue growth in our Products and Upgrade revenue categories.
"During this quarter, we made significant progress in our new product development efforts. As a result, we plan to introduce a new product before the end of 2010 and we expect to introduce a second new product at the American Academy of Dermatology meeting in February 2011. We are excited about these two new upcoming product launches that will enhance our product offerings and expand our market reach."
Mr. Connors added, "We remain focused on key initiatives to increase future revenue levels and leverage our business model, which we expect will result in improved profitability. While the near-term prospects for our industry are difficult to predict, we believe that our worldwide distribution network, strong balance sheet with approximately $100 million in cash and investments - with no debt - a broad portfolio of products, and various research and development projects underway, offer continuing, long-term opportunities for our company."
The conference call to discuss these results is scheduled to begin at 2:00 p.m. PT (5:00 p.m. ET) on August 2, 2010. The call will be broadcast live over the Internet hosted at the Investor Relations section of Cutera's website at www.cutera.com, and will be archived online within one hour of its completion through 8:59 p.m. PT (11:59 p.m. ET) on August 16, 2010. In addition, you may call (877) 407-0784 to listen to the live broadcast. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to leverage its business model, increase revenue, manage costs and expenses, generate additional cash, increase profitability, develop and commercialize existing and new products and applications, and statements regarding long-term prospects and opportunities are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include the current economic uncertainty, which may reduce consumer demand for its products, cause potential customers to delay their purchase decisions and make it more difficult for some potential customers to obtain credit financing; its ability to increase revenue, manage costs and expenses and improve sales productivity and performance worldwide; its ability to successfully develop and acquire new products and applications and market them to both its installed base and new customers; the length of the sales cycle process; unforeseen events and circumstances relating to its operations; government regulatory actions; and those other factors described in the section entitled, "Risk Factors," in its most recent Form 10-Q as filed with the Securities and Exchange Commission on August 2, 2010. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. Cutera's second quarter ended June 30, 2010 financial performance, as discussed in this release, is preliminary and unaudited, and subject to adjustment.
| CUTERA, INC. | ||||||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||||
| (in thousands) | ||||||||||||
| (unaudited) | ||||||||||||
| June 30, | March 31, | December 31, | ||||||||||
| 2010 | 2010 | 2009 | ||||||||||
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | $ | 31,697 | $ | 22,519 | $ | 22,829 | ||||||
| Marketable investments | 60,317 | 73,733 | 76,780 | |||||||||
| Accounts receivable, net | 3,824 | 3,488 | 3,327 | |||||||||
| Inventories | 6,955 | 6,953 | 6,408 | |||||||||
| Deferred tax asset | 185 | 178 | 175 | |||||||||
| Other current assets and prepaid expenses | 3,020 | 3,190 | 2,785 | |||||||||
| Total current assets | 105,998 | 110,061 | 112,304 | |||||||||
| Property and equipment, net | 708 | 796 | 847 | |||||||||
| Long-term investments | 7,115 | 7,153 | 7,275 | |||||||||
| Intangibles, net | 733 | 781 | 829 | |||||||||
| Deferred tax asset, net of current portion | 97 | 97 | 97 | |||||||||
| Total assets | $ | 114,651 | $ | 118,888 | $ | 121,352 | ||||||
| Liabilities and Stockholders' Equity | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | $ | 1,495 | $ | 1,898 | $ | 1,081 | ||||||
| Accrued liabilities | 5,922 | 7,328 | 9,048 | |||||||||
| Deferred revenue | 5,898 | 6,270 | 6,160 | |||||||||
| Total current liabilities | 13,315 | 15,496 | 16,289 | |||||||||
| Deferred rent | 1,303 | 1,398 | 1,493 | |||||||||
| Deferred revenue, net of current portion | 1,373 | 1,594 | 1,968 | |||||||||
| Income tax liability | 732 | 729 | 749 | |||||||||
| Total liabilities | 16,723 | 19,217 | 20,499 | |||||||||
| Stockholders' equity: | ||||||||||||
| Common stock | 14 | 13 | 13 | |||||||||
| Additional paid-in capital | 88,189 | 86,150 | 85,248 | |||||||||
| Retained earnings | 11,475 | 15,236 | 17,254 | |||||||||
| Accumulated other comprehensive loss | (1,750 | ) | (1,728 | ) | (1,662 | ) | ||||||
| Total stockholders' equity | 97,928 | 99,671 | 100,853 | |||||||||
| Total liabilities and stockholders' equity | $ | 114,651 | $ | 118,888 | $ | 121,352 |
| CUTERA, INC. | ||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||
| (in thousands, except per share data) | ||||||||||||
| (unaudited) | ||||||||||||
| Three Months Ended | ||||||||||||
| June 30, | March 31, | June 30, | ||||||||||
| 2010 | 2010 | 2009 | ||||||||||
| Net revenue | $ | 12,217 | $ | 13,749 | $ | 11,665 | ||||||
| Cost of revenue | 5,335 | 5,829 | 5,130 | |||||||||
| Gross profit | 6,882 | 7,920 | 6,535 | |||||||||
| Operating expenses: | ||||||||||||
| Sales and marketing | 6,452 | 6,361 | 6,071 | |||||||||
| Research and development | 1,506 | 1,454 | 1,495 | |||||||||
| General and administrative | 2,744 | 2,242 | 3,616 | |||||||||
| Total operating expenses | 10,702 | 10,057 | 11,182 | |||||||||
| Loss from operations | (3,820 | ) | (2,137 | ) | (4,647 | ) | ||||||
| Interest and other income, net | 141 | 166 | 511 | |||||||||
| Loss before income taxes | (3,679 | ) | (1,971 | ) | (4,136 | ) | ||||||
| Provision (benefit) for income taxes | 82 | 47 | (1,772 | ) | ||||||||
| Net Loss | $ | (3,761 | ) | $ | (2,018 | ) | $ | (2,364 | ) | |||
| Net loss per share: | ||||||||||||
| Basic | $ | (0.28 | ) | $ | (0.15 | ) | $ | (0.18 | ) | |||
| Diluted | $ | (0.28 | ) | $ | (0.15 | ) | $ | (0.18 | ) | |||
| Weighted-average number of shares used in per share calculations: | ||||||||||||
| Basic | 13,501 | 13,438 | 13,317 | |||||||||
| Diluted | 13,501 | 13,438 | 13,317 |
| CUTERA, INC. | ||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||
| (in thousands) | ||||||||||||
| (unaudited) | ||||||||||||
| Three Months Ended | ||||||||||||
| June 30, | March 31, | June 30, | ||||||||||
| 2010 | 2010 | 2009 | ||||||||||
| Cash flows from operating activities: | ||||||||||||
| Net loss | $ | (3,761 | ) | $ | (2,018 | ) | $ | (2,364 | ) | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
| Stock-based compensation | 1,761 | 828 | 1,456 | |||||||||
| Tax benefit from stock-based compensation | - | - | (87 | ) | ||||||||
| Depreciation and amortization | 199 | 194 | 225 | |||||||||
| Provision for excess and obsolete inventories | 109 | (23 | ) | 130 | ||||||||
| Provision for doubtful accounts receivable | (2 | ) | (82 | ) | 498 | |||||||
| Gain on sale of marketable investments, net | 23 | 43 | - | |||||||||
| Change in deferred tax asset | (7 | ) | (3 | ) | 139 | |||||||
| Changes in assets and liabilities: | ||||||||||||
| Accounts receivable | (334 | ) | (79 | ) | 1,936 | |||||||
| Inventories | (111 | ) | (522 | ) | 1,014 | |||||||
| Other current assets and prepaid expenses | 689 | 252 | (1,053 | ) | ||||||||
| Accounts payable | (403 | ) | 817 | (408 | ) | |||||||
| Accrued liabilities | (1,446 | ) | (1,760 | ) | (429 | ) | ||||||
| Deferred rent | (55 | ) | (55 | ) | (55 | ) | ||||||
| Deferred revenue | (593 | ) | (264 | ) | (957 | ) | ||||||
| Income tax liability | 3 | (20 | ) | (54 | ) | |||||||
| Net cash used in operating activities | (3,928 | ) | (2,692 | ) | (9 | ) | ||||||
| Cash flows from investing activities: | ||||||||||||
| Acquisition of property and equipment | (63 | ) | (95 | ) | (36 | ) | ||||||
| Proceeds from sales of marketable and long-term investments | 14,711 | 14,990 | 9,774 | |||||||||
| Proceeds from maturities of marketable investments | 5,200 | 14,125 | 1,100 | |||||||||
| Purchase of marketable and long-term investments | (7,021 | ) | (26,712 | ) | (11,342 | ) | ||||||
| Net cash provided by (used in) investing activities | 12,827 | 2,308 | (504 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||
| Proceeds from exercise of stock options and employee stock purchase plan | 279 | 74 | 165 | |||||||||
| Net cash provided by financing activities | 279 | 74 | 165 | |||||||||
| Net increase (decrease) in cash and cash equivalents | 9,178 | (310 | ) | (348 | ) | |||||||
| Cash and cash equivalents at beginning of period | 22,519 | 22,829 | 35,793 | |||||||||
| Cash and cash equivalents at end of period | $ | 31,697 | $ | 22,519 | $ | 35,445 |
| CUTERA, INC. | |||||||||||||||
| CONSOLIDATED REVENUE HIGHLIGHTS | |||||||||||||||
| (in thousands, except percentage data) | |||||||||||||||
| (unaudited) | |||||||||||||||
| Three Months Ended | |||||||||||||||
| June 30, | % of | March 31, | % of | June 30, | % of | ||||||||||
| 2010 | Revenue | 2010 | Revenue | 2009 | Revenue | ||||||||||
| Revenue By Geography: | |||||||||||||||
| United States | $ | 4,784 | 39% | $ | 4,547 | 33% | $ | 4,551 | 39% | ||||||
| International | 7,433 | 61% | 9,202 | 67% | 7,114 | 61% | |||||||||
| $ | 12,217 | $ | 13,749 | $ | 11,665 | ||||||||||
| Revenue By Product Category: | |||||||||||||||
| Products (1) | $ | 5,676 | 46% | $ | 7,445 | 54% | $ | 5,142 | 44% | ||||||
| Product upgrades | 1,338 | 11% | 1,203 | 9% | 1,201 | 10% | |||||||||
| Service | 3,437 | 28% | 3,314 | 24% | 3,397 | 29% | |||||||||
| Titan refills | 960 | 8% | 1,322 | 10% | 1,403 | 12% | |||||||||
| Dermal fillers and cosmeceuticals (1) | 806 | 7% | 465 | 3% | 522 | 4% | |||||||||
| $ | 12,217 | $ | 13,749 | $ | 11,665 | ||||||||||
| (1) Beginning in 2010, we classified revenue from dermal filler and cosmeceuticals product in the revenue category Dermal filler and cosmeceuticals.' Previously, we classified these sales in the revenue category Products.' As such, we reclassified the 2009 revenue from Products' to Dermal filler and cosmeceuticals.' |